Revisions of Previously Issued Financial Statements (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Dec. 31, 2020 |
Jun. 30, 2020 |
Jun. 30, 2020 |
|
Net loss per share | $ (0.25) | $ (0.46) | $ (0.54) | $ (0.83) | ||
As reported [Member] | ||||||
Change in fair value of derivative liability | ||||||
Net loss attributable to Akerna shareholders | $ (16,957,334) | $ (15,534,345) | ||||
Net loss per share | $ (1.06) | $ (1.31) | ||||
Adjustment [Member] | ||||||
Change in fair value of derivative liability | $ 746,852 | $ 1,962,034 | ||||
Net loss attributable to Akerna shareholders | $ 746,852 | $ 1,962,034 | ||||
Net loss per share | ||||||
As revised [Member] | ||||||
Change in fair value of derivative liability | $ 746,852 | $ 1,962,034 | ||||
Net loss attributable to Akerna shareholders | $ (16,210,482) | $ (13,572,311) | ||||
Net loss per share | $ (1.01) | $ (1.14) |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|